Table A2.
Clinicopathological parameters and survival of patients with CTCs.
| Age | Sex | UICC-Stage | pT | pN | M | G | R | VI | PNI | CTCs/ 7.5 mL | CSS [mo] | DFS [mo] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | m | St. IIb | 3 | 1 | 0 | 4 | 0 | 1 | 1 | 33 | 2.5 | 0.5 |
| 65 | m | St. IIb | 3 | 1 | 0 | 3 | 0 | 1 | 1 | 1 | 14.1 | 9.7 |
| 71 | m | St. IIb | 3 | 1 | 0 | 2 | 1 | 0 | 1 | 1 | 7.8 | 2.5 |
| 70 | m | St. IIb | 3 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 19.6 | 14.3 |
| 69 | m | St. IIb | 3 | 1 | 0 | 2 | 1 | 0 | 1 | 1 | 6.6 | 2.0 |
| 76 | f | St. IIb | 3 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 4.7 | 3.9 |
| 57 | m | St. IIb | 3 | 1 | 0 | 2 | 0 | 1 | 1 | 1 | 5.1 | 3.3 |
Demographics and basic clincopathological parameters of CTC-positive patients with CTC-number and survival metrics. VI: vessel infiltration; PNI: neural infiltration; CSS: cancer specific survival; DFS: disease-free survival.